ZR2 Bioenergy (506640)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trading below book value: P/B of 0.78 versus book value of ₹422.73 offers a potential margin of safety if stated assets are realistic.
• Profit growth of 188.46% indicates some earnings recovery, albeit from a very low base.
• Piotroski F-Score of 5/9 suggests the company is not in immediate financial distress.
• Market cap of ₹120 Cr makes it a small, possibly neglected name where assets may be underpriced.

Concerns

• Latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, indicating no active revenue generation.
• ROCE of 0.00% and ROE of only 0.66% show capital is not generating meaningful returns.
• P/E of 241.38 is unjustifiable with near-zero earnings, and sales growth is 0.00%.
• Commodity chemicals is a price-taker business with no obvious moat; promoter holding data is unavailable, adding governance uncertainty.

AI Analysis

Let's look at ZR2 Bioenergy. A ₹120 Cr market cap chemical company, but the first thing I notice is the latest quarter shows zero sales and zero profit. You can't run a valuation on a business that isn't producing anything. The trailing P/E of 241.38 is meaningless when earnings are near zero, and the 188.46% profit growth is likely from a tiny base. Return on capital is 0.00%; equity earns only 0.66%. This is not a compounding machine. What catches my Graham eye is the balance sheet: book value ₹422.73 against a price of ₹330, so P/B is 0.78. In theory, I pay 78 paise for a rupee of stated assets. But in commodity chemicals, book value can be inventory, receivables, or plants that are worth far less when forced to sell. With zero revenue, the assets are either idle or being liquidated. Sales growth is 0.00%, and ROCE is zero, so there is no demonstrated ability to turn those assets into profits. The Piotroski score of 5/9 is mediocre, and the PEG of 1.28 relies on profit growth that may not continue. I don't invest in hopeful balance sheets; I invest in businesses. This looks more like an asset play than a going concern. If management can put the assets to work and produce real revenue, there may be value. Until then, the margin of safety is only as good as the true liquidation value of the assets, which I cannot verify from these numbers. I would need far more data and evidence of capital allocation before putting money here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer